Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Microglia and Oxidative Neuroprotection: Study Summary

Previous related pageVitamin D, Microglia and Oxidative Neuroprotection: Full StudyNext related pageVitamin D, Microglia and Oxidative Neuroprotection: Full Study
Study at a glance

How was vitamin D tested in nerve cells, brain immune cells and worms?

Researchers used rodent nerve cells grown in the laboratory, microglia and worms to investigate vitamin D-related responses to injury. Microglia are immune cells in the brain. Cell experiments tested active vitamin D and changes in the amount of vitamin D receptor, the protein that receives vitamin D signals. They did not test supplements in people with diseases of the brain or nerves.

Did active vitamin D reduce signs of cell injury?

Active vitamin D or extra receptor reduced selected signs of chemical stress and partly preserved a measurement related to the cell’s energy-producing structures. Some signals of inflammation and damage to cell membranes also fell in microglia. Reducing receptor production generally worsened injury-related responses. These tests did not directly measure whole-brain energy production, long-term nerve-cell survival or a reduction in every inflammatory process.

Could the enzyme DUB3 help explain the cell responses?

An enzyme called DUB3 increased the amount of receptor protein without a matching increase in the RNA instructions for making it. Other experiments suggested that DUB3 helped the receptor last longer. Changing DUB3 also changed some injury responses. However, the study did not prove that every protective effect required the vitamin D receptor; other proteins could be involved.

Do these findings show a treatment for Parkinson’s disease?

Worm experiments are not human brain experiments. One protein signal was measured in worm muscle, and the worms received vitamin D3 rather than the active hormone used in the cells grown in the laboratory. Some method descriptions were inconsistent, and the cell experiments were repeated independently only a few times. The findings support further research, but do not establish Parkinson’s disease prevention or treatment, improved thinking ability, or a safe and effective supplement dose.

Read the full article below ↓

Experiments in cultured rodent cells and worms suggest that vitamin D receptor signalling can influence selected neuronal injury and microglial inflammatory responses. A 2024 study also linked an enzyme called DUB3 to receptor stability. These findings support further mechanistic research, but do not establish protection against neurological disease in people. For the detailed methods and appraisal, read Vitamin D, Microglia and Oxidative Neuroprotection: Full Study.

What was tested

Zheng and colleagues studied neurons, microglia and several worm strains. Microglia are immune cells within the brain. Neuronal cultures were challenged with rotenone, a mitochondrial toxin; microglial cultures received fluid from cells engineered to produce more alpha-synuclein. The researchers applied calcitriol, the active vitamin D hormone, and separately increased or reduced vitamin D receptor expression.

What changed in the cells

Calcitriol or increased receptor expression reduced an oxidant-sensitive fluorescence signal and partly preserved a mitochondrial membrane-potential measurement. These are relevant to oxidative stress, but do not directly measure whole-brain energy production or long-term neuronal survival. Reducing receptor expression generally worsened the injury-related responses.

In microglia, the interventions reduced selected inflammasome-related signals, caspase-1 activity and measures of membrane injury. An inflammasome is a protein complex involved in inflammatory signalling. The measurements support a bounded cellular effect; they do not demonstrate that every inflammatory process was suppressed or that one specific cell-death mechanism explains all the findings.

Why receptor stability matters

Increasing DUB3 raised receptor protein abundance without a significant corresponding rise in receptor messenger RNA. Protein-turnover and association experiments supported a role in stabilising the receptor. DUB3 manipulation also changed injury responses, but the study did not establish that every protective DUB3 effect required the receptor. Other molecular targets remain possible.

Limits of the evidence

The worm experiments add biological observations but cannot be treated as human brain experiments. The alpha-synuclein reporter in one strain was expressed in muscle. Worm vitamin D3 exposure also differed from the calcitriol used in mammalian cultures, and a related worm receptor does not establish an identical human signalling mechanism.

Several methods descriptions are inconsistent, including the species named for primary neuronal cultures and the timing of worm gene suppression. Cell experiments used small replicate numbers, and the statistical report incompletely identifies its multiple-comparison procedure. These issues limit confidence in exact reconstruction and broad generalisation.

The complete article and supplementary material support a model-specific hypothesis connecting receptor signalling, protein stability and cellular stress. They do not establish prevention or treatment of Parkinson’s disease, a safe or effective supplement dose, or improved cognition. Clinical benefit requires direct human evidence rather than extrapolation from protective laboratory signals.

Scientific sources

Zheng Z, Chen M, Feng S, Zhao H, Qu T, Zhao X, Ruan Q, Li L, Guo J. VDR and deubiquitination control neuronal oxidative stress and microglial inflammation in Parkinson’s disease. Cell Death Discovery. 2024;10:150. DOI: 10.1038/s41420-024-01912-9. PMID: 38514643. The complete principal paper, seven figures, supplementary figures S1: S8 and supplementary tables S1: S3 were examined.

Related reading

Original sources

Source

VDR and deubiquitination control neuronal oxidative stress and microglial inflammation in Parkinson’s disease

Published in Cell Death Discovery (2024).

Publication details

Zheng Z, Chen M, Feng S, Zhao H, Qu T, Zhao X, Ruan Q, Li L, Guo J. VDR and deubiquitination control neuronal oxidative stress and microglial inflammation in Parkinson’s disease. Cell Death Discovery. 2024;10:150. DOI: 10.1038/s41420-024-01912-9. PMID: 38514643. The complete principal paper, seven figures, supplementary figures S1: S8 and supplementary tables S1: S3 were examined.

Read more →